Skip to main content
Veterinary Medicines

EXCENEL FLOW 50 MG/ML SUSPENSION FOR INJECTION FOR PIGS AND CATTLE

Authorised
  • Ceftiofur hydrochloride

Product identification

Medicine name:
EXCENEL FLOW 50 MG/ML SUSPENSION FOR INJECTION FOR PIGS AND CATTLE
EXCENEL EVO, 50 mg/ml, injekcinė suspensija kiaulėms ir galvijams
Active substance:
  • Ceftiofur hydrochloride
Target species:
  • Pig
  • Cattle
Route of administration:
  • Intramuscular use
  • Subcutaneous use

Product details

Active substance and strength:
  • Ceftiofur hydrochloride
    53.50
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Pig
      • Meat and offal
        2
        day
  • Subcutaneous use
    • Cattle
      • Meat and offal
        6
        day
      • Milk
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01DD90
Authorisation status:
  • Valid
Authorised in:
  • Lithuania
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Zoetis Belgium
Marketing authorisation date:
Manufacturing sites for batch release:
  • Zoetis Belgium SA
Responsible authority:
  • State Food And Veterinary Service
Authorisation number:
  • LT/2/12/2107/001-003
Date of authorisation status change:
Reference member state:
  • France
Procedure number:
  • FR/V/0102/001
Concerned member states:
  • Austria
  • Belgium
  • Cyprus
  • Estonia
  • Germany
  • Greece
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Luxembourg
  • Malta
  • Portugal
  • Slovenia
  • Spain
  • United Kingdom (Northern Ireland)

Documents

RV2107.pdf

Lithuanian (PDF)
Published on: 3/12/2024
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."